Works matching DE "PHARMACEUTICAL industry mergers"
Results: 132
Drug Industry Mergers Won't Necessarily Benefit R&D.
- Published in:
- Research Technology Management, 2000, v. 43, n. 4, p. 10, doi. 10.1080/08956308.2000.11671362
- By:
- Publication type:
- Article
Merger of Glaxo Wellcome and SmithKline Beecham creates pharmaceutical giant.
- Published in:
- Nature, 2000, v. 403, n. 6767, p. 232, doi. 10.1038/35002148
- By:
- Publication type:
- Article
Drugs merger seeks strength in breadth.
- Published in:
- Nature, 1998, v. 391, n. 6668, p. 621, doi. 10.1038/35449
- By:
- Publication type:
- Article
Novartis heads research table.
- Published in:
- Nature, 1997, v. 385, n. 6611, p. 5
- Publication type:
- Article
Eli Lilly to buy Novartis' animal health unit for $5.4bn.
- Published in:
- Veterinary Ireland Journal, 2014, v. 4, n. 5, p. 238
- Publication type:
- Article
Shire acquires NPS Pharmaceuticals for $5.2 billion.
- Published in:
- Optometry Times, 2015, v. 7, n. 2, p. 18
- Publication type:
- Article
Acquiring Pharmaceutical Industry Assets in the UK: 1 + 1 = 1?
- Published in:
- Pharmaceutical Medicine, 2014, v. 28, n. 5, p. 245, doi. 10.1007/s40290-014-0066-2
- By:
- Publication type:
- Article
ROCHE TO ACQUIRE SPARK THERAPEUTICS.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 3, p. 14
- Publication type:
- Article
TAKEDA AGREES TO $62 BILLION TAKEOVER OF SHIRE.
- Published in:
- Applied Clinical Trials, 2018, v. 27, n. 6, p. 13
- Publication type:
- Article
CRO: FEDERAL TAX SUPPORT KEEPS AUSTRALIA COMPETITIVE FOR CLINICAL TRIALS.
- Published in:
- Applied Clinical Trials, 2018, v. 27, n. 6, p. 12
- Publication type:
- Article
Michigan's next wave of biopharmaceutical entrepreneurship.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 9, p. 1109, doi. 10.1038/nbt0903-1109
- By:
- Publication type:
- Article
Changing partners.
- Published in:
- 2002
- Publication type:
- Editorial
Pfizer?Pharmacia merger bodes ill for biotech?
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 9, p. 857, doi. 10.1038/nbt0902-857
- By:
- Publication type:
- Article
Anti-Inversion Rules, the Pfizer-Allergan Merger, and the U.S. Chamber of Commerce's Challenge.
- Published in:
- Review of Banking & Financial Law, 2016, v. 36, n. 1, p. 16
- By:
- Publication type:
- Article
Concentration via Consolidation in the Indian Pharmaceutical Industry: An Inquiry.
- Published in:
- ICFAI Journal of Mergers & Acquisitions, 2008, v. 5, n. 4, p. 51
- By:
- Publication type:
- Article
Relaciones laborales en fusiones y adquisiciones transnacionales. Una aproximación política.
- Published in:
- Revista Española de Investigaciones Sociológicas, 2007, n. 120, p. 11, doi. 10.2307/40184832
- By:
- Publication type:
- Article
PHARMACY SUPERGROUP LAUNCHED.
- Published in:
- Australian Journal of Pharmacy, 2016, v. 97, p. 6
- Publication type:
- Article
CWH CONSORTIUM TO TAKE OVER MASTERS STORES.
- Published in:
- Australian Journal of Pharmacy, 2016, v. 97, p. 10
- Publication type:
- Article
MERGER TO CREATE PHARMACY GIANT.
- Published in:
- Australian Journal of Pharmacy, 2016, v. 97, p. 6
- Publication type:
- Article
Big pharma's mega-mergers contribute to growth.
- Published in:
- Australian Journal of Pharmacy, 2010, v. 91, n. 1077, p. 52
- Publication type:
- Article
Using Mergers and Acquisitions and Socratic Pedagogy to Facilitate Critical Thinking on Relevance versus Faithful Representation in Financial Reporting.
- Published in:
- Journal of the Academy of Business Education, 2015, v. 16, p. 110
- By:
- Publication type:
- Article
UK must ward off pharmageddon.
- Published in:
- TCE: The Chemical Engineer, 2014, n. 876, p. 3
- By:
- Publication type:
- Article
Sun Pharma buys Ranbaxy for US$4bn.
- Published in:
- TCE: The Chemical Engineer, 2014, n. 875, p. 12
- Publication type:
- Article
Actavis buys Forest for US$25bn.
- Published in:
- TCE: The Chemical Engineer, 2014, n. 873, p. 8
- Publication type:
- Article
Pharma consolidation continues.
- Published in:
- TCE: The Chemical Engineer, 2010, n. 826, p. 6
- Publication type:
- Article
Fourth time lucky: Roche seals deal on Genentech merger.
- Published in:
- TCE: The Chemical Engineer, 2009, n. 814, p. 5
- Publication type:
- Article
Merck and Schering-Plough to merge.
- Published in:
- TCE: The Chemical Engineer, 2009, n. 814, p. 5
- Publication type:
- Article
Takeda buys Millennium Pharma.
- Published in:
- TCE: The Chemical Engineer, 2008, n. 803, p. 8
- Publication type:
- Article
So Tell Me Again, Why Are We Doing This?
- Published in:
- Bio-IT World, 2010, v. 9, n. 1, p. 12
- By:
- Publication type:
- Article
Roche buys $1 billion majority stake in Foundation.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 3, p. 155, doi. 10.1038/nrd4568
- By:
- Publication type:
- Article
Market watch: Biopharma deal-making in 2014: a record year for M&A value.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 2, p. 84, doi. 10.1038/nrd4536
- By:
- Publication type:
- Article
ANALIZA MEÐUNARODNIH SPAJANJA I PREUZIMANJA U FARMACEUTSKOJ INDUSTRIJI.
- Published in:
- Ekonomski Vjesnik, 2011, v. 24, n. 1, p. 11
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- RAND Journal of Economics (Wiley-Blackwell), 2017, v. 48, n. 3, p. 555, doi. 10.1111/1756-2171.12151
- Publication type:
- Article
Mergers with interfirm bundling: a case of pharmaceutical cocktails.
- Published in:
- RAND Journal of Economics (Wiley-Blackwell), 2017, v. 48, n. 3, p. 810, doi. 10.1111/1756-2171.12192
- By:
- Publication type:
- Article
THE FDA AND THE PHARMACEUTICAL INDUSTRY: IS REGULATION CONTRIBUTING TO DRUG SHORTAGES?
- Published in:
- Albany Law Review, 2014, v. 77, n. 2, p. 539
- By:
- Publication type:
- Article
Big drug company created.
- Published in:
- Nature, 1989, v. 338, n. 6217, p. 610, doi. 10.1038/338610a0
- By:
- Publication type:
- Article
Making Up Is Hard to Do: Knowledge Acquisition Strategies and the Nature of New Product Innovation.
- Published in:
- Journal of Product Innovation Management, 2016, v. 33, n. 4, p. 472, doi. 10.1111/jpim.12298
- By:
- Publication type:
- Article
In This Issue.
- Published in:
- Journal of Product Innovation Management, 2016, v. 33, n. 4, p. 380, doi. 10.1111/jpim.12324_1
- By:
- Publication type:
- Article
The current M&A environment and its strategic implications for emerging biotherapeutics companies.
- Published in:
- 2010
- Publication type:
- Abstract
Pfizer aborts Allergan deal.
- Published in:
- TCE: The Chemical Engineer, 2016, n. 899, p. 17
- Publication type:
- Article
Pfizer is world's biggest drug firm after swallowing Allergan.
- Published in:
- TCE: The Chemical Engineer, 2015, n. 894/895, p. 17
- Publication type:
- Article
In a rare deal, Shire buys Dyax.
- Published in:
- TCE: The Chemical Engineer, 2015, n. 894/895, p. 7
- Publication type:
- Article
Teva buying Allergan Generics for US$40.5bn.
- Published in:
- TCE: The Chemical Engineer, 2015, n. 891, p. 8
- Publication type:
- Article
Pfizer to buy Hospira in US$17bn deal.
- Published in:
- TCE: The Chemical Engineer, 2015, n. 885, p. 6
- Publication type:
- Article
Actavis buys Botox maker Allergan for US$66bn.
- Published in:
- TCE: The Chemical Engineer, 2014, n. 882, p. 8
- Publication type:
- Article
Glaxo SmithKline Merge Into World's Biggest Drug Firm.
- Published in:
- Ageing International, 1999, v. 25, n. 3, p. 4
- By:
- Publication type:
- Article
Predicting Competitive Effects from Prescription Drug Mergers: How Standard Economic Analysis Can Go Wrong.
- Published in:
- Antitrust Bulletin, 2014, v. 59, n. 3, p. 593, doi. 10.1177/0003603X1405900309
- By:
- Publication type:
- Article
FTC v. Lundbeck: Is Anything in Antitrust Obvious, Like, Ever?
- Published in:
- Antitrust Bulletin, 2014, v. 59, n. 3, p. 557, doi. 10.1177/0003603X1405900307
- By:
- Publication type:
- Article
Hatteras rounds up $90 million to lead biotech rebound in North Carolina.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 11, p. 1121, doi. 10.1038/nbt1115-1121
- By:
- Publication type:
- Article
Amgen bulks out cardio package.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 11, p. 1118, doi. 10.1038/nbt1115-1118a
- Publication type:
- Article